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Background:The left atrial septal pouch (LASP), an anatomic variant of the interatrial sep-
tum, has uncertain clinical significance. We examined the association between LASP and
ischemic stroke subtypes in patients undergoing transesophageal echocardiography (TEE).
Methods:We determined the prevalence of LASP among consecutive patients who under-
wentTEE at our institution. Patients identified with ischemic strokes were further evaluated
for stroke subtype using standard and modified criteria from the Trial of Org 10172 in
Acute StrokeTreatment (TOAST). We compared the prevalence of LASP in ischemic stroke,
cryptogenic stroke, and non-stroke patients using prevalence ratios (PR).
Results: The mean age of all 212 patients (including stroke and non-stroke patients) was
57 years. The overall prevalence of LASP was 17% (n=35). Of the 75 patients who were
worked-up for stroke at our institution during study period, we classified 31 as cryptogenic
using standardTOAST criteria. The prevalence of LASP among cryptogenic stroke patients
(using standard and modified TOAST criteria) was increased compared to the prevalence
among other ischemic stroke patients (26 vs. 9%, p= 0.06; PR=1.8, 95% CI=1.1–3.1,
and 30 vs. 10%, p=0.04; PR=2.2, 95% CI=1.2–4.1, respectively).
Conclusion: In this population of relatively young patients, prevalence of LASP was
increased in cryptogenic stroke compared to stroke patients of other subtypes. These
findings suggest LASP is associated with cryptogenic stroke, which should be verified by
future large-scale studies.
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INTRODUCTION
Upwards of 40% of ischemic strokes are of unknown etiology
and are known as “cryptogenic” (1). The left atrial septal pouch
(LASP), an anatomic variant of the atrial septum (2), may be a site
of thrombus formation resulting in cardioembolic stroke. Prior
case reports describe thrombi along the left atrial septum in the
setting of ischemic stroke or transient ischemic attack (TIA) (3–6),
and we have previously described LASP in the setting of crypto-
genic stroke (7). A case-control study demonstrated no association
between LASP and ischemic or cryptogenic stroke (8); however,
that study population was limited to patients older than 50 years
of age, and mean age of stroke subjects was over 70 years. The
primary aim of the present study was to determine if LASP is asso-
ciated with cryptogenic stroke in a population that includes young
subjects.
Abbreviations: ASD, atrial septal defect; CI, confidence interval; LASP, left atrial
septal pouch; PFO, patent foramen ovale; OR, odds ratio; PR, prevalence ratio; TEE,
transesophageal echocardiography; TIA, transient ischemic attack; TOAST, Trial
of Org 10172 in Acute Stroke Treatment; UCIMC, University of California Irvine
Medical Center.
MATERIALS AND METHODS
In this cross-sectional study, we retrospectively evaluated 718
consecutive patients (with or without stroke) who underwent a
transesophageal echocardiogram (TEE) between July 2008 and
June 2011 at the University of California, Irvine Medical Cen-
ter (UCIMC). Patients were excluded from analysis (Figure 1)
if the atrial septum was not adequately visualized or if agitated
saline injections were not administered (n= 430); agitated saline
injections with Valsalva maneuver is the standard maneuver for
evaluating the presence of patent foramen ovale (PFO) (9, 10). Of
the remaining 288 study subjects, we excluded patients with an
atrial septal defect (ASD) or PFO (n= 76 or 26%) as was done in
prior study of LASP and stroke risk (8), because these entities have
previously been associated with cryptogenic stroke (11).
We performed a chart review (history, physical exam, consulta-
tions, and outpatient notes) for the remaining 212 eligible patients
to determine history of hypertension, hyperlipidemia, diabetes
mellitus, atrial fibrillation/flutter, ischemic stroke or TIA, coro-
nary artery disease, and congestive heart failure. Of the 92 patients
with current or prior ischemic stroke, 75 were worked-up for
ischemic stroke at UCIMC during the study period. Stroke was
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718 consecutive patients 
undergoing TEE
212 patients included in 
the analysis
430 patients with agitated saline 
not administered or with atrial 
septum inadequately visualized
76 patients with atrial septal 
defect or with patent foramen 
ovale
14 TIA106 no
stroke/TIA
92 ischemic 
stroke
17 Prior ischemic 
stroke only
75 Current ischemic 
stroke with work-up 
FIGURE 1 | Flowchart outlining the study exclusion process. TEE,
transesophageal echocardiogram.
verified by review of magnetic resonance imaging of the brain and
vascular imaging (by computed tomography, magnetic resonance,
ultrasound, and/or arteriography). These 75 patients were sub-
typed by one vascular neurologist according to criteria developed
for the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
(12). Ischemic strokes were classified into one of five categories:
large artery atherosclerosis, cardioembolic, lacunar, other deter-
mined cause, and cryptogenic. We also used modified TOAST
criteria, in which ischemic strokes with multiple competing iden-
tified etiologies were excluded from the cryptogenic category.
For example, a patient with atrial fibrillation and severe carotid
artery stenosis would be excluded from the modified cryptogenic
stroke group. This group represents an ischemic stroke popu-
lation that is without any identifiable etiology by conventional
work-up. The neurologist was blinded to the presence of LASP.
Inter-observer agreement using TOAST criteria has been studied
previously and shown to be reliable (13). The study was approved
by the Institutional Review Board of UCIMC.
All TEEs were interpreted by two of four cardiology fellows. The
cardiologists were blinded to all patient information, including
whether or not the patient experienced a stroke. The intera-
trial septum was inspected using 2-dimensional echocardiography
and one of four anatomical possibilities was recorded: fused sep-
tum, LASP, PFO, or ASD. A LASP was defined as fusion at the
caudal limit of the zone of overlap between the septum pri-
mum and septum secundum, whereby a blind-ending pouch is
formed that communicates exclusively with the LA (Figure 2).
The presence of a PFO was determined if microbubbles were seen
in the LA after agitated saline injections were administered and
Valsalva maneuver was performed by the patient. The presence
of a PFO was also confirmed by the original echocardiography
report. Any differences in interpretation between the cardiology
fellows were adjudicated by a third cardiologist and director of the
echocardiography laboratory (DL).
STATISTICAL ANALYSIS
We compared differences in stroke risk factors in patients with and
without LASP using the Chi-square test of proportions for cate-
gorical variables (Fisher’s exact test for 2× 2 tables) and t -tests
for continuous variables. The Kappa statistic was used to calculate
agreement above chance among the raters of LASP. We determined
the LASP prevalence ratio (PR), which is preferable to the odds
ratio in cross-sectional studies (14), using two sets of compari-
son groups: (1) patients without a history of ischemic stroke or
TIA (n= 106), and (2) patients presenting with non-cryptogenic
ischemic strokes (n= 44 by TOAST and n= 52 by modified
TOAST). Multiple logistic regression analysis was performed to
see if the effect of LASP on stroke risk was changed by adjusting
for age (continuous), gender, and the stroke risk factors of atrial
fibrillation/flutter, congestive heart failure, coronary artery disease,
diabetes mellitus, ever-smoker, hyperlipidemia, hypertension, and
prior history of ischemic stroke. Predictors were included in the
final model if the p value was <0.15. A p value of <0.05 was con-
sidered statistically significant for other analyses. All analyses were
performed using STATA (version 12.0, StataCorp, College Station,
TX, USA).
RESULTS
The mean age of all 212 subjects (including stroke and non-stroke)
was 57 years. The age range for the 92 ischemic stroke patients
was 16–90 years and for the 106 non-ischemic stroke patients was
16–86 years. The overall prevalence of LASP was 17% (n= 35).
The Kappa statistics comparing the agreement between each rater
combination ranged from 0.70 to 0.83, indicating good to very
good agreement. The distribution of demographic information
and ischemic stroke risk factors by the presence of LASP is shown
in Table 1. No variable was statistically different between the two
groups.
There were 92 subjects with ischemic stroke, 14 with a TIA
history, and 106 without a history of ischemic stroke or TIA
(Figure 1). The prevalence of LASP among these subgroups was:
20, 14, and 14%, respectively. Subjects who were worked-up at
UCIMC for ischemic stroke during the study period (n= 75) were
further characterized by stroke subtype using standard TOAST
criteria: large artery atherosclerosis= 19, cardioembolic= 8, lacu-
nar= 8, other determined etiology= 9, cryptogenic= 31.
Table 2 shows the prevalence of LASP among patients with
no ischemic stroke/TIA, ischemic stroke, and cryptogenic or
non-cryptogenic stroke. The prevalence of LASP in cryptogenic
stroke patients using standard TOAST criteria was nearly triple
that compared with non-cryptogenic ischemic stroke patients
(26 vs. 9%, p= 0.06; PR= 1.8, 95% CI= 1.1–3.1). This associ-
ation was greater and statistically significant when using modified
TOAST criteria to define cryptogenic stroke (30 vs. 10%, p= 0.04;
PR= 2.2, 95% CI= 1.2–4.1). The prevalence of LASP among the
other stroke subtypes were 5.3% for large artery atherosclerosis
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FIGURE 2 |Transesophageal echocardiogram image of the left atrial septal pouch. Transeophageal echocardiogram image of the left atrial septal pouch
(arrow). LA, left atrium, RA, right atrium.
Table 1 | Patient characteristics categorized by the presence or
absence of LASP.
Covariate LASP
(n=35)
No LASP
(n=177)
p-value
Demographics
Age, years (mean±SD) 57±17 57±15 0.78
Male sex (%) 20 (57) 106 (60) 0.85
Stroke risk factors (%)a
Atrial fibrillation/Flutter (%) 12 (34) 44 (25) 0.30
Congestive heart failure (%) 7 (20) 28 (16) 0.62
Coronary artery disease (%) 7 (20) 34 (20) 1.00
Diabetes mellitus (%) 10 (29) 51 (29) 1.00
Ever-smoker (%) 14 (40) 65 (37) 0.85
Hyperlipidemia (%) 14 (40) 75 (43) 0.85
Hypertension (%) 17 (49) 115 (66) 0.06
Prior ischemic stroke (%) 8 (23) 21 (12) 0.09
LASP, left atrial septal pouch; SD, standard deviation.
aThree persons with missing values.
(n= 1), 13% for cardioembolic (n= 1), 0% for lacunar (n= 0),
and 22% for other determined etiology (n= 2).
There was no significant difference in prevalence of atrial fib-
rillation/flutter in patients with or without LASP (34 vs 25%,
p= 0.30). No patient with cryptogenic stroke (standard or mod-
ified TOAST criteria) had evidence of atrial fibrillation/flutter.
In multivariate analyses comparing LASP in cryptogenic stroke
patients vs. patients who had no history of stroke/TIA, adjust-
ment for age, gender, and stroke risk factors (see Table 1) did
not significantly change the effect size using standard TOAST cri-
teria (OR= 2.3 vs. 2.1) or modified TOAST criteria (OR= 2.3
vs. 2.7).
Table 2 | Prevalence of the left atrial septal pouch among ischemic and
cryptogenic stroke populations.
Subgroup No.
LASP/
total
LASP
prevalence
(%)
Prevalence
ratio
(95% CI)
p-value
No stroke/TIA 15/106 14 1.2 (0.9–1.7) 0.31
All ischemic strokesa 18/92 20
TOAST criteriab
Non-cryptogenic 4/44 9 1.8 (1.1–3.1) 0.06
Cryptogenic 8/31 26
ModifiedTOAST criteriac
Non-cryptogenic 5/52 10 2.2 (1.2–4.1) 0.04
Cryptogenic 7/23 30
CI, confidence interval; LASP, left atrial septal pouch; TIA, transient ischemic
attack.
aIncludes current and prior ischemic stroke, with subtyping performed for 75
ischemic stroke patients who were worked-up for stroke at UCIMC during the
study period.
bCryptogenic stroke defined as either (1) no likely etiology despite extensive
evaluation or (2) two OR more potential causes.
cCryptogenic stroke defined as (1) no likely etiology despite extensive evaluation.
DISCUSSION
This study is the first to demonstrate evidence for an association
between LASP and cryptogenic stroke. Among 212 patients who
underwent TEE at UCIMC, LASP was roughly twice as preva-
lent among cryptogenic ischemic stroke patients compared to
non-cryptogenic stroke patients. Our findings suggest that some
individuals are susceptible to cardioembolism from LASP.
In utero, the interatrial septum consists of a separated sep-
tum primum and septum secundum, forming a conduit known
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as the foramen ovale (2). A LASP is formed when these septa
fuse incompletely, creating a blind-ending pouch that commu-
nicates exclusively with the left atrium. The LASP may behave
similarly to the left atrial appendage, the site where thrombi
most commonly form in patients with non-valvular atrial fib-
rillation (15). Current mechanistic theories as to why thrombi
have been observed within the LASP include intra-pouch stasis
and chronic inflammation at the site of the pouch (4). Gurude-
van and Krishnan proposed that brisk laminar flow along the
interatrial septum protects against thrombus formation in the
LASP (4).
Our findings contrast with a case-control study by Tugco
and colleagues (8), which found no association between LASP
and ischemic or cryptogenic stroke in 187 first-ever ischemic
stroke patients (of which 69 were cryptogenic). A few possibili-
ties might explain why our findings are not consistent. First, our
study population consisted of hospitalized patients across all age
groups referred for TEE who were predominantly Hispanic or
Caucasian, whereas the prior study included first-time ischemic
stroke patients who were older than 50 years of age and were pre-
dominantly Hispanic or African–American (>80%). Since many
ischemic stroke patients do not routinely undergo TEE, our study
is subjected to selection bias. However, we selected this patient
population because it tends to have higher prevalence of crypto-
genic strokes. Although our study was not designed to have the
power for analysis of subgroups by age, younger patients may be
more likely to experience cryptogenic stroke in the setting of LASP.
The process of fusion between the septum primum and septum
secondum may be dynamic after birth, and the size and extent of
blood stasis of the LASP may decrease with age (2). Second, the
prevalence of LASP among our control group was smaller, perhaps
due to differences in LASP prevalence across different populations
or differences in the accuracy of LASP diagnosis. Nonetheless,
despite a relatively small statistical power, we detected a statistically
different prevalence of LASP among patients with cryptogenic
stroke. A more recent report also noted no association of LASP
with cryptogenic stroke, although the latter was defined differ-
ently and apparently included small deep infarcts/lacunar strokes
(16).
There are several study limitations to be considered. The
absolute number of cryptogenic stroke subjects and absolute dif-
ference in LASP between cryptogenic and non-cryptogenic stroke
subjects was relatively small, affecting the study’s statistical power
and ability to detect a statistical difference of the prevalence of
LASP between some subgroups. Because this was a retrospec-
tive cross-sectional study, we could not determine whether LASP
increases cryptogenic stroke risk longitudinally or directly medi-
ates cryptogenic stroke. A significant number of patients were
excluded because either the atrial septum was not well-visualized
or saline contrast injection was not performed, which may have
affected LASP prevalence rates in this cohort. It is possible that
antiplatelet or anticoagulant use at the time of stroke, which was
not captured in our study, differed between patients with and
without LASP. Additionally, detection of atrial fibrillation/flutter
was made by chart review only; increasing evidence supports sub-
clinical atrial fibrillation as an under-diagnosed risk factor for
cryptogenic stroke (17, 18) and therefore it is possible that our
cohort had higher rates of undetected atrial fibrillation. Finally,
while LASP prevalence rates were increased for cryptogenic stroke
patients, prevalence rates were not significantly increased for the
entire group of ischemic stroke patients as compared to non-stroke
patients.
In conclusion, the LASP is a recently discovered anatomic entity
and our findings suggest that its presence is associated with cryp-
togenic stroke. This should be verified by future large-scale studies.
Further research is warranted to understand the pathophysiology
of LASP and the conditions which may promote its thrombogenic
potential (19).
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